Clinical Trials and Studies
Some clinical trials have suspended enrollment until further notice due to COVID-19 considerations.
Blood Disorders and Hematologic Cancers
- Advanced Systemic Mastocytosis Treatment Study
- Assessing the Anti-Tumor Activity and Safety of REGN1979 in Patients with Relapsed or Refractory Follicular Lymphoma
- Cell-Based Therapy Study for Patients with Multiple Myeloma
- Chronic Graft-Versus-Host Disease Treatment Study
- Chronic Lymphocytic Leukemia in Patients 70 Years of Age and Older Treatment Study
- Chronic Lymphocytic Leukemia in Younger Patients Treatment Study
- Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease Treatment Study
- Clinical Study for Acute Myeloid Leukemia Patients with FLT3 Mutation
- Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype Treatment Study
- Diffuse Large B-Cell Lymphoma Treatment Study
- Drug Treatment Study for Children with Hemophilia A
- Drug Treatment Study for High Grade B-Cell Lymphomas
- Drug Treatment Study for Patients with Follicular Lymphoma
- Evaluation of Pediatric Palliative Inpatient Process
- FLT3 Mutated Acute Myeloid Leukemia Treatment Study
- Follicular Lymphoma Treatment Study
- Health Literacy and Numeracy in Adolescent Patients with Hemophilia A and B Study
- Hemophilia A or B Treatment Study
- Hemophilia A Treatment Study
- High-Risk or Hard to Treat Acute Graft Versus Host Disease Treatment Study
- Hodgkin Lymphoma and CD30-Expressing Peripheral T-cell Lymphoma Treatment Study
- Maintenance Study For Patients With Residual Myeloma Post-Transplant
- Mantle Cell Lymphoma Treatment Study
- Molecular and Clinical Biology of von Willebrand Disease Study
- MYC-Associated B-Cell Lymphomas Treatment Study
- Myelofibrosis Treatment Study
- National Registry of All Persons with Bleeding and Clotting Disorders
- Newly Diagnosed T-Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma Treatment Study
- Nivolumab and Combination Chemotherapy in Treating Participants with Diffuse Large B-Cell Lymphoma
- Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders
- Relapsed or Refractory Follicular Lymphoma Treatment Study
- Relapsed or Refractory Mantle Cell Lymphoma Treatment Study
- Relapsed or Refractory Non-Hodgkin’s B-Cell Lymphoma Treatment Study
- Relapsed/Refractory Hodgkin Lymphoma Treatment Study
- Specimen Collection from ALL or CML Patients for the Xpert BCR-ABL Ultra p190 Test
- Specimen Collection from ALL or CML Patients with a Detectable BCR-ABL p190 Fusion Transcript Level
- Study for Patients with Acute Lymphoblastic Leukemia
- Study for Patients with Acute Myelogenous Leukemia
- Study for Patients with Acute Myeloid Leukemia
- Study of Biomarkers in Hemophilic Arthropathy
- Study of Hepatitis C Virus Outcomes After Treatment in Patients with Bleeding Disorders
- Study Treating Patients With High-Risk Smoldering Myeloma
- Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia
- The National Myelodysplastic Syndromes Study
- Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma Study
- Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Study
- Treatment Study for Children with Hemophilia B
- Treatment Study for Newly Diagnosed High Risk B-Lymphoblastic Leukemia in Patients with Ph-like TKI Sensitive Mutations
- Treatment Study for Older Patients with Acute Lymphoblastic Leukemia
- Treatment Study for Patients with Cutaneous T-Cell Lymphoma
- Treatment Study for Patients with Diffuse Large B-Cell Lymphoma After aHCT
- Treatment Study for Patients with FLT3/ITD Acute Myeloid Leukemia in First Complete Remission
- Treatment Study for Patients with HER2-Expressing Cancers
- Treatment Study for Patients with Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
- Treatment Study for Patients with Localized Central Nervous System Germ Cell Tumors
- Treatment Study for Patients with Marginal Zone Lymphoma
- Treatment Study for Patients with Myelofibrosis
- Treatment Study for Patients with Newly Diagnosed B-Lymphoblastic Leukemia or B-Lineage Lymphoblastic Lymphoma
- Treatment Study for Patients with Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
- Treatment Study for Patients with Rare Tumors
- Treatment Study for Patients with Relapsed or Refractory Non-Hodgkin’s B-cell Lymphoma
- Treatment Study for Patients with Relapsed/Refractory T-Cell Lymphoma
- Treatment Study for Patients with Untreated Mantle Cell Lymphoma
- Treatment Study for Pediatric Patients with Hemophilia A
- Treatment Study for Relapsed or Hard to Treat Indolent Non-Hodgkin’s Lymphoma
- Treatment Study for Subjects with Myelofibrosis Who Have Failed a JAK Inhibitor
- Treatment Study for Subjects with Severe Hemophilia A or B
- Treatment Study for the Mycosis Fungoides Form of Cutaneous T-Cell Lymphoma
- Treatment Study for Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia